Mind and Brain Blog - Mind and Brain Institute

Should Patients with Schizophrenia be Treated with Antipsychotics Forever?

25. August 2018/0 Comments/in Antipsychotics, Schizophrenia /by Gerhard Gründer

A Finnish registry study examined the risk of rehospitalization or death in almost 9000 patients with the first episode of schizophrenia over an observation period of 20 years.

“Digital Phenotyping” in German Broadcast

9. August 2018/0 Comments/in Artificial Intelligence, Big Data, Digital Phenotype /by Gerhard Gründer

A brief radio feature on “Digital Phenotyping” was broadcasted on August 8, 2018, on Deutschlandfunk.

Big Data in Psychiatry – Brave New World?

2. August 2018/0 Comments/in Big Data, Digital Phenotype, Machine Learning, Precision Medicine /by Gerhard Gründer

“Big Data”, “Precision Medicine” and “Machine Learning” are praised as the solution of all problems in psychiatry. However, critical questions are rarely discussed.

IQWiG: Indication of an Added Benefit of Cariprazine

20. July 2018

The Institute for Quality and Efficiency in Health Care (IQWiG) on July 16, 2018, published its opinion on cariprazine as part of its „benefit assessment“. It concludes that there is an "indication" that cariprazine has a "non-quantifiable added benefit" in the group of patients with schizophrenia with predominant negative symptoms.

Withdrawal and Emotional Blunting with Chronic Antidepressant Treatment

How Common are Withdrawal and Emotional Blunting in Chronic Antidepressant Treatment?

15. July 2018

The problem of withdrawal syndromes and emotional blunting occurring with prolonged antidepressant treatment is constantly underestimated by clinicians.

A Lecture on the "Crisis in Psychopharmacology"

7. July 2018

Lecture on "The Crisis of Psychopharmacology" at the scientific colloquium of the Department of Psychiatry and Psychotherapy of the University of Rostock.

Finally: A New Psychotropic Drug in Germany - Cariprazine

5. May 2018

Recordati launched the new antipsychotic cariprazine in Germany in Mid-April. The benefit assessment by the G-BA has therefore started.

The Antidepressant Debate in the New York Times

18. April 2018

An article on the front page of the New York Times on April 7, 2018, has fueled the debate over antidepressants again.

DGPPN Summer School "Psychopharmacology" 2018 in Berlin

11. April 2018

On June 28 and 29, 2018, the Summer School "Psychopharmacology", organized by the German Society for Psychiatry and Psychotherapy, Psychosomatics and Neuroscience (DGPPN), will be held in Berlin.

The Mental Health Crisis in Graduate Education

9. April 2018

In the March issue of Nature Biotechnology, Teresa Evans of the University of San Antonio, Texas, and co-authors point out that there is "Evidence for a mental health crisis in graduate education".

Antipsychotics for long-term treatment - when to stop? Or better not?

1 Comment

2. April 2018

A new publication in the prestigious Lancet Psychiatry seems to provide new evidence for the benefits of long-term antipsychotic maintenance treatment in schizophrenia (Hui et al., Lancet Psychiatry 2018). On closer inspection, however, the paper confuses more than it provides new insights.

"Langzeittherapie mit Psychopharmaka" bei Frag-den-Professor

28. March 2018

My presentation on "long-term treatment with psychotropic drugs" ("Langzeittherapie mit Psychopharmaka") on the web platform "Frag-den-Professor".

How effective are antidepressants?

1 Comment

13. March 2018

Andrea Cipriani from the University of Oxford and colleagues have recently published the largest and most comprehensive meta-analysis of the efficacy of antidepressants in the Lancet. The paper is worth dealing with more intensively.

A lecture on polypharmacy and pharmacokinetics

3. March 2018

A video of my lecture on "Polypharmacy and Pharmacokinetics", which I gave at the "Psychiatrie-Akademie" in Brugg, Switzerland on January 11th, 2018. This talk was given in German.

Job Offer Central Institute of Mental Health

Join me me at the Central Institute of Mental Health

10. February 2018

Work with me at the Central Institute of Mental Health (CIMH) in Mannheim and build with me the future of psychiatry.

A brief report from the 56th ACNP annual meeting

19. December 2017

The American College of Neuropsychopharmacology held its annual meeting between December 3rd and 7th, 2017, in Palm Springs, California. Here is a brief report of some of the meeting highlights.

Brainfoods has launched its first products: Mindme Drinks

19. November 2017

The company, which I founded with my sons Nikolaj and Philipp, Brainfoods GmbH, has just launched pre sales of our first three products, Mindme® Drinks.

Thanks for a great time together!

12. November 2017

The staff of my unit at the Department of Psychiatry, Psychotherapy and Psychosomatics at RWTH Aachen University organized a farewell party for me.

Would you talk to a machine therapist?

1. November 2017

Miner and colleagues from Stanford University believe that machine psychotherapists based on artificial intelligence could revolutionize mental health care.

Viktor Frankl on the Power of “Meaning” and the Conception of Psychiatry

1 Comment

24. October 2017

Viennese psychiatrist Viktor Frankl on the power of "meaning" man has to find in life and his conception of a rehumanized psychiatry.

"The new paths of psychiatry" in WDR

15. October 2017

The Westdeutscher Rundfunk (WDR) on October 8th and 9th, 2017, broadcasted an interesting feature on the "new paths of psychiatry", which contains many statements I made during an interview on the future of psychopharmacology.